Arkansas Administrative Code › Agency 006 - Department of Finance and Administration › Division 06 - Racing Commission › Rule 006.06.21-010 - Thoroughbred Rule 1217.5 Uniform Guidelines for Foreign Substances and Recommended Penalties Model Rule

Current through Register Vol. 49, No. 6, June, 2024
Uniform Classiflcation Guidelines for Foreign Substances
				and Recommended Penalties.
Uniform Classification Guidelines for Foreign Substances And
				Recommended Penalties Model Rule.
December, 2020 (V.14.4)
© ASSOCIATION OF RACING COMMISSIONERS INTERNATIONAL -
				2020.
Association of Racing Commissioners International 2365
				Harrodsburg Road, Suite B-450, Lexington, Kentucky USA 40504
www.arci.com
Preamble to the Uniform Classification Guidelines of
				Foreign Substances
The Preamble to the Uniform Classification Guidelines was
				approved by the RC1 Drug Testing and Quality Assurance Program Committee (now
				the Drug Testing Standards and Practices Program Committee) on August 26, 1991.
				Minor revisions to the Preamble were made by the Drug Classification
				subcommittee (now the Veterinary Pharmacologists Subcommittee) on September 3,
				1991.
''The Uniform Classification Guidelines printed on the
				following pages are intended to assist stewards, hearing officers and racing
				commissioners in evaluating the seriousness of alleged violations of medication
				and prohibited substance rules in racing jurisdictions. Practicing equine
				veterinarians, state veterinarians, and equine pharmacologists are available
				and should be consulted to explain the pharmacological effects of the drugs
				listed in each class prior to any decisions with respect to penalities to be
				imposed. The ranking of drugs is based on their pharmacology, their ability to
				influence the outcome of a race, whether or not they have legitimate
				therapeutic uses in the racing horse, or other evidence that they may be used
				improperly. These classes of drugs are intended only as guidelines and should
				be employed only to assist persons adjudicating facts and opinions in
				understanding the seriousness of the alleged offenses. The facts of each case
				are always different and there may be mitigating circumstances which should
				always be considered. These drug classifications will be reviewed frequently
				and new drugs will be added when appropriate."
Notes Regarding Classification Guidelines
* Where the use of a drug is specifically permitted by a
				jurisdiction, then the jurisdiction's rule supersedes these penalty
				guidelines.
* Regulators should be aware that a laboratory report may
				identify a drug only by the name of its metabolite. The metabolite might not be
				listed here, but the parent compound may be.
* These classes of drugs are intended only as guidelines and
				should be employed only to assist persons adjudicating facts and opinions in
				understanding the seriousness of the alleged offenses.
* The facts of each case are different and there may be
				mitigating circumstances that should be considered.
* These drug classifications will be reviewed periodically. New
				drugs will be added or some drugs may be reclassified when appropriate.
* Racing Commissioners International (RCI) and/or the Racing
				Medication and Testing Consortium (RMTC) should be consulted for found
				substances or drugs not included in these guidelines and treated as Class 1
				violations warranting a Class A penalty unless otherwise advised.
Classification Criteria
The RCI Drug Classification Scheme is based on 1) pharmacology,
				2) drug use patterns, and 3) the appropriateness of a drug for use in the
				racing horse. Categorization is decided using the following general
				guidelines:
*
Pharmacology.
Drugs that are known to be
				potent stimulants or depressants are placed in higher classes, while those that
				have (or would be expected to have) little effect on the outcome of a race are
				placed in lower classes.
*
Drug Use Patterns
Some consideration is
				given to placement of drugs based on practical experience with their use and
				the nature of positive tests. For example, procaine positives have in the past
				been associated primarily with the administration of procaine penicillin, and
				this has been taken into consideration in the placement of procaine into Class
				3 instead of Class 2 with other injectable local anesthetics.
*
Appropriateness of Drug Use.
Drugs that
				clearly are intended for use in equine therapeutics are placed in lower
				classes. Drugs that clearly arc not intended for use in the horse are placed in
				higher classes, particularly if they might affect the outcome of a race. Drugs
				that are recognized as legitimately useful in equine therapeutics but could
				affect the outcome of a race are placed in the middle or higher classes.
The list includes most drugs that have been reported as
				detected by racing authority laboratories in the United States, Canada, the
				United Kingdom and other Association of Official Racing Chemists (AORC)
				laboratories, but does not include those which would seem to have no effect on
				the performance of the horse or drug detectability. For example, it does not
				include antibiotics, sulfonamides, vitamins, anthelmintics, or pangamic acid,
				all of which have been reported.
The list contains many drugs that have never been reported as
				detected. Usually, these are representatives of chemical classes that have the
				potential for producing an effect, and in many cases, for which at least one
				drug in that chemical class has been reported.
Most drugs have numerous effects, and each was judged on an
				individual basis. There are instances where there is a rather fine distinction
				between drugs in one category' and those in the next. This is a reflection of a
				nearly continuous spectrum of effects from the most innocuous drug on the list
				to the drug that is the most offensive.
Classification Definitions
* Class 1: Stimulant and depressant drugs that have the highest
				potential to affect performance and that have no generally accepted medical use
				in the racing horse. Many of these agents are Drug Enforcement Agency (DEA)
				schedule II substances. These include the following drugs and their
				metabolites: Opiates, opium derivatives, synthetic opioids and psychoactive
				drugs, amphetamines and amphetamine-like drugs as well as related drugs,
				including but not limited to apomorphine, nikethamide, mazindol, pemoline, and
				pentylenetetrazol. Though not used as therapeutic agents, all DEA Schedule 1
				agents are included in Class 1 because they are potent stimulant or depressant
				substances with psychotropic and often habituative actions. This class also
				includes all erythropoietin stimulating substances and their analogues.
* Class 2: Drugs that have a high potential to affect
				performance, but less of a potential than drugs in Class 1. These drugs are 1)
				not generally accepted as therapeutic agents in racing horses, or 2) they are
				therapeutic agents that have a high potential for abuse. Drugs in this class
				include: psychotropic drugs, certain nervous system and cardiovascular system
				stimulants, depressants, and neuromuscular blocking agents. Injectable local
				anesthetics are included in this class because of their high potential for
				abuse as nerve blocking agents.
* Class 3: Drugs that may or may not have generally accepted
				medical use in the racing horse, but the pharmacology of which suggests less
				potential to affect performance than drugs in Class 2. Drugs in this class
				include bronchodilators, anabolic steroids and other drugs with primary effects
				on the autonomic nervous system, procaine, antihistamines with sedative
				properties and the high-ceiling diuretics.
* Class 4: This class includes therapeutic medications that
				would be expected to have less potential to affect performance than those in
				Class 3. Drugs in this class includes less potent diuretics; corticosteroids;
				antihistamines and skeletal muscle relaxants without prominent central nervous
				system (CNS) effects; expectorants and mucolytics; hemostatics; cardiac
				glycosides and anti-arrhythmics; topical anesthetics; antidiarrheals and mild
				analgesics. This class also includes the non-steroidal anti-inflammatory drugs
				(NSAIDs), at concentrations greater than established limits.
* Class 5: This class includes those therapeutic medications
				that have very localized actions only, such as anti-ulcer drugs, and certain
				anti-allergic drugs. The anticoagulant drugs are also included.
*
Prohibited Practices:
A) The possession and/or use of a drug,
			 substance or medication, specified below, on the premises of a facility under
			 the jurisdiction of the regulatory body for which a recognized analytical
			 method has not been developed to detect and confirm the administration of such
			 substance; or the use of which may endanger the health and welfare of the horse
			 or endanger the safety of the rider or driver; or the use of which may
			 adversely affect the integrity of racing:
1)
			 Erythropoietin
2)
			 Darbepoetin
3) Oxyglobin
4) Hemopure